+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Hot Flash Drug"

Vasomotor symptoms (Hot flashes/Night sweats) - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Vasomotor symptoms (Hot flashes/Night sweats) - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • June 2024
  • 200 Pages
  • Global
From
Menopausal Hot Flash Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Thumbnail Image

Menopausal Hot Flash Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • November 2024
  • 150 Pages
  • Global
From
Vasomotor symptoms (Hot flashes/Night sweats) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Vasomotor symptoms (Hot flashes/Night sweats) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
  • 3 Results (Page 1 of 1)
Loading Indicator

The Hot Flash Drug market is a subset of the Sexual and Reproductive Health Drugs market. Hot Flash Drugs are used to treat the symptoms of menopause, such as hot flashes, night sweats, and vaginal dryness. These drugs are typically hormone replacement therapies, such as estrogen and progesterone, or selective serotonin reuptake inhibitors (SSRIs). Hot Flash Drugs are used to reduce the severity and frequency of hot flashes, as well as to improve overall quality of life. The Hot Flash Drug market is highly competitive, with many companies offering different types of drugs. Some of the major players in the market include Pfizer, Novartis, Merck, and Eli Lilly. Other companies include Bayer, GlaxoSmithKline, and AstraZeneca. Show Less Read more